Cardinal Health, Inc. (CAH)
| Market Cap | 25.10B |
| Revenue (ttm) | 216.15B |
| Net Income (ttm) | 639.00M |
| Shares Out | 243.23M |
| EPS (ttm) | 2.56 |
| PE Ratio | 40.32 |
| Forward PE | 13.59 |
| Dividend | $2.00 (1.94%) |
| Ex-Dividend Date | Mar 28, 2024 |
| Volume | 1,395,834 |
| Open | 103.20 |
| Previous Close | 103.81 |
| Day's Range | 102.93 - 103.94 |
| 52-Week Range | 77.56 - 116.04 |
| Beta | 0.70 |
| Analysts | Buy |
| Price Target | 103.00 (-0.2%) |
| Earnings Date | May 2, 2024 |
About CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segmen... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for CAH stock is "Buy." The 12-month stock price forecast is $103.0, which is a decrease of -0.20% from the latest price.
News
US FDA sends warning to Cardinal Health for marketing unapproved devices
The U.S. Food and Drug Administration on Thursday sent a warning letter to Cardinal Health after an inspection of its facility in Illinois showed that the company was marketing unapproved devices.
Cardinal Health Won't Renew OptumRx Distribution Pact. Guidance Is Unchanged.
The pharmaceutical distribution contract with OptumRx will expire in June.
Cardinal Health says contracts with UnitedHealth's OptumRx will not be renewed
Cardinal Health said on Monday its pharma distribution contracts with UnitedHealth Group Inc's OptumRx unit will not be renewed after they expire at the end of June.
Cardinal Health's stock slides 3.6% after announcing contract with OptumRx will not be renewed after end-June
Cardinal Health Inc. ‘s stock CAH, +2.07% fell 3.6% early Monday, after the pharmaceuticals distributor and medical lab products maker said its contracts with pharmacy benefits manager OptumRx will ex...
Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts
DUBLIN, Ohio , April 22, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be...
Cardinal Health announces location of pharmaceutical distribution center for over-the-counter products
The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio , April 2, 2024 /PRNewswire/ -- Today, C...
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2024 on May 2
DUBLIN, Ohio , March 26, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New...
Cardinal Health announces approved science-based climate targets; expands focus across the supply chain
DUBLIN, Ohio , March 15, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term scienc...
Cardinal Health annual research report examines milestone year in biosimilars
Study reveals impact of dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability DUBLIN, Ohio , Feb. 29, 2024 /PRNewswire/...
Bob Azelby to join Cardinal Health Board of Directors
DUBLIN, Ohio , Feb. 28, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors has elected Robert "Bob" Azelby as an independent director, effective March 1. Mr. ...
Final Trades: Invesco's Equal Weight Energy ETF, Cardinal Health and Shake Shack
Today's “Halftime Report” Investment Committee, Bryn Talkington, Josh Brown and Jason Snipe, give their top picks to watch for the second half.
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio , Feb. 6, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surp...
Cardinal Health publishes Fiscal 2023 Environmental, Social and Governance (ESG) Report
DUBLIN, Ohio , Feb. 6, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today released its Fiscal 2023 Environmental, Social and Governance (ESG) Report, highlighting the company's work toward buildin...
Cardinal Health lowers medical unit profit forecast, shares fall
Cardinal Health lowered the full-year profit forecast for its medical segment on Thursday, taking the shine off the company's upbeat second-quarter results and sending its shares down more than 5%.
Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
Revenue increased 12% to $57.4 billion GAAP1 operating earnings were $482 million; GAAP diluted EPS was $1.43 Non-GAAP operating earnings increased 20% to $562 million; non-GAAP diluted EPS increased ...
Cardinal Health to buy Specialty Networks for $1.2 billion in cash to boost analytics capabilities
Cardinal Health Inc. CAH, +0.73% announced Wednesday an agreement to buy Specialty Networks for $1.2 billion in cash. Cardinal said the acquisition expands its offering in therapeutic areas by boostin...
Cardinal Health to buy private tech firm for $1.2 billion
Cardinal Health said on Wednesday it will buy Specialty Networks, a private company that provides technological solutions for healthcare organizations, for $1.2 billion in cash.
Cardinal Health to acquire Specialty Networks and its PPS Analytics platform, a technology enabled multi-specialty group purchasing and practice enhancement organization in urology, rheumatology and gastroenterology
Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates platform...
Cardinal Health's stock rises in range of a record after upbeat profit outlook
Shares of Cardinal Health Inc. CAH, -0.52% rallied 1.7% in premarket trading Tuesday, after the drug distributor said it expects fiscal 2024 earnings to be at the high-end of previous guidance. The st...
Cardinal Health Announces Progress on Business and Portfolio Review and Fiscal 2024 Outlook Update
Progress achieved on company's ongoing business and portfolio review Completed review of growth businesses within the Medical Segment: investing in and further developing at-Home Solutions and OptiFre...
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2024 on February 1
DUBLIN, Ohio , Jan. 2, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1, prior to the opening of trading on th...
Cardinal Health launches SmartGown™ EDGE Breathable Surgical Gown with ASSIST™ Instrument Pockets
SmartGown™ EDGE is the first pocketed surgical gown designed to help maintain instrument sterility and accessibility. DUBLIN, Ohio , Nov. 9, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced ...
Cardinal Health's stock rises into record territory after profit beat, raised outlook
Shares of Cardinal Health Inc. CAH, +0.21% climbed 1.3% into record territory in premarket trading Friday, after the drug distributor reported fiscal first-quarter profit that beat expectations and ra...
Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
Revenue increased 10% to $54.8 billion GAAP 1 operating loss was $14 million and GAAP diluted EPS was $0.02, driven by a Medical segment goodwill impairment Non-GAAP operating earnings increased 35% t...
